- $524.69m
- $532.34m
- $26.00m
- 61
- 55
- 78
- 70
Annual income statement for Upexi, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | R2022 June 30th | R2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.41 | 24.1 | 23.1 | 36.4 | 26 |
Cost of Revenue | |||||
Gross Profit | 2.57 | 11.9 | 14.9 | 21 | 12.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12.8 | 21.9 | 29.3 | 48.7 | 48.5 |
Operating Profit | -5.43 | 2.22 | -6.19 | -12.3 | -22.5 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.38 | 1.7 | -6.39 | -17 | -25.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.38 | 2.98 | -5.87 | -13.9 | -25.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.38 | 2.98 | -2.1 | -16.9 | -23.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.38 | 2.93 | -2.1 | -16.9 | -23.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.35 | 0.169 | -0.377 | -12.2 | -18.9 |
Dividends per Share |